RT Journal Article
T1 Application of Low-Intensity Modified Constraint-Induced Movement Therapy to Improve the Affected Upper Limb Functionality in Infantile Hemiplegia with Moderate Manual Ability: Case Series.
A1 Palomo-Carrión, Rocío
A1 Romero-Galisteo, Rita-Pilar
A1 Pinero-Pinto, Elena
A1 López-Muñoz, Purificación
A1 Romay-Barrero, Helena
A1 José, Francisco García-Muro San
K1 family
K1 infantile hemiplegia
K1 modified Constraint-Induced Movement Therapy
K1 physical therapy modalities
K1 upper extremity
AB To assess the functionality of the affected upper limb in children diagnosed with hemiplegia aged between 4 and 8 years after applying low-intensity modified Constraint-Induced Movement Therapy (mCIMT). Prospective case series study. A mCIMT protocol was applied for five weeks, with two hours of containment per day. The study variables were quality of movement of the upper limb, spontaneous use, participation of the affected upper limb in activities of daily living, dynamic joint position, grasp-release action, grasp strength, supination and extension elbow movements. Four measurements were performed, using the quality of upper extremity test (QUEST) scale, the Shriners Hospital for Children Upper Extremity Evaluation (SHUEE) Evaluation, a hand dynamometer and a goniometer. The sample was composed of eight children with moderate manual ability. Statistically significant differences were detected in all the studied variables (p  0.05). The greatest increase occurred in spontaneous use from Assessment 1 to Assessment 4 (p = 0.01), reaching 88.87% active participation in bimanual tasks. The quality of movement of the upper limb exhibited a significant value due to the increase in dissociated movements and grasp (p = 0.01). A low dose (50 h) of mCIMT increased the functionality of children diagnosed with congenital hemiplegia between 4 and 8 years of age with moderate manual ability.
SN 2227-9067
YR 2020
FD 2020-09-04
LK https://hdl.handle.net/10668/28402
UL https://hdl.handle.net/10668/28402
LA en
DS RISalud
RD Apr 6, 2025